Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
988
datasets available to search
ShareScore release 0.9.0
Dataset results
988 results for “platinum”
A Phase I/II Trial of HCB101 in Combination With Pembrolizumab for Patients With Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (SirH&N Trial)
ClinicalTrials.gov study NCT07136545. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
HIPEC After Secondary Cytoreductive Operation in Patients With Platinum-sensitive Recurrence of Ovarian Carcinoma
ClinicalTrials.gov study NCT02487849. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma (ECTOP-1002)
ClinicalTrials.gov study NCT02980991. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of Pemetrexed in the Treatment of Patients With Ovarian Cancer Who Have Failed Prior Platinum-Based Chemotherapy
ClinicalTrials.gov study NCT00109096. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Efficacy and Safety of Use of Platinum Based Doublet Chemotherapy Plus Antiangiogenesis and Immune Checkpoint Inhibitors in Patients With Advanced Non-squamous Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04137588. IPD Sharing: Not stated. Countries: 1. Publications: 0.
FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum
ClinicalTrials.gov study NCT06393816. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer
ClinicalTrials.gov study NCT00230542. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SCT200 Plus Platinum-based Chemotherapy in Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT03874741. IPD Sharing: Not stated. Countries: 1. Publications: 0.
IN10018 in Combination With Pegylated Liposomal Doxorubicin (PLD) vs. Placebo in Combination With PLD for the Treatment of Platinum-resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT06014528. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Toripalimab in Combination With Platinum-based Chemotherapy for Mutation-negative Stage IV Oligometastatic NSCLC
ClinicalTrials.gov study NCT05055583. IPD Sharing: NO. Countries: 1. Publications: 0.
Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of E
ClinicalTrials.gov study NCT06951841. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04262869. IPD Sharing: NO. Countries: 0. Publications: 0.
A Study of Vebreltinib and Platinum-Containing Double Agents in Subjects With MET-Positive
ClinicalTrials.gov study NCT06930794. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based Chemotherapy
ClinicalTrials.gov study NCT00081107. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of Anlotinib and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Lung Cancer.
ClinicalTrials.gov study NCT07307443. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of 225Ac-ABD147 to Establish Optimal Dose in Patients With SCLC and LCNEC of the Lung That Previously Received Platinum-based Chemotherapy
ClinicalTrials.gov study NCT06736418. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Randomized Phase II, Open-label Efficacy and Safety Study of Second-line Durvalumab Plus Tremelimumab Versus Platinum-based Chemotherapy Alone in Patients With NSCLC and First-line Checkpoint-inhibito
ClinicalTrials.gov study NCT05383001. IPD Sharing: NO. Countries: 1. Publications: 0.
ASKC202 Combined With Limertinib Versus Platinum-based Chemotherapy in Treatment of Locally Advanced or Metastatic NSCLC With MET Amplification/Overexpression After Failure of EGFR-TKI Therapy
ClinicalTrials.gov study NCT07109531. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Maintenance With Niraparib In Patients With Advanced Urothelial Cancer After 1st-line Platinum-based Chemotherapy
ClinicalTrials.gov study NCT03945084. IPD Sharing: NO. Countries: 1. Publications: 0.
Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy
ClinicalTrials.gov study NCT04188860. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.